JPMorgan Chase & Co’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-133,328
| Closed | -$493K | – | 4878 |
|
|
2017
Q4 | $493K | Buy |
133,328
+43,915
| +49% | +$162K | ﹤0.01% | 3348 |
|
|
2017
Q3 | $367K | Buy |
89,413
+88,083
| +6,623% | +$362K | ﹤0.01% | 3285 |
|
|
2017
Q2 | $5K | Sell |
1,330
-11,253
| -89% | -$42.3K | ﹤0.01% | 4157 |
|
|
2017
Q1 | $52K | Buy |
+12,583
| New | +$52K | ﹤0.01% | 3916 |
|
|
2016
Q2 | – | Sell |
-75,833
| Closed | -$577K | – | 4466 |
|
|
2016
Q1 | $577K | Sell |
75,833
-5,182
| -6% | -$39.4K | ﹤0.01% | 2881 |
|
|
2015
Q4 | $1.08M | Sell |
81,015
-13,190
| -14% | -$176K | ﹤0.01% | 2649 |
|
|
2015
Q3 | $1.55M | Sell |
94,205
-1,510
| -2% | -$24.8K | ﹤0.01% | 2482 |
|
|
2015
Q2 | $2.15M | Buy |
95,715
+1,332
| +1% | +$29.9K | ﹤0.01% | 2488 |
|
|
2015
Q1 | $923K | Sell |
94,383
-15,517
| -14% | -$152K | ﹤0.01% | 2864 |
|
|
2014
Q4 | $1.25M | Buy |
109,900
+64,150
| +140% | +$731K | ﹤0.01% | 2696 |
|
|
2014
Q3 | $527K | Buy |
+45,750
| New | +$527K | ﹤0.01% | 2994 |
|
|
2014
Q2 | – | Sell |
-5,918
| Closed | -$106K | – | 3580 |
|
|
2014
Q1 | $106K | Buy |
+5,918
| New | +$106K | ﹤0.01% | 3408 |
|
|
2013
Q4 | – | Sell |
-4,144
| Closed | -$51K | – | 3879 |
|
|
2013
Q3 | $51K | Sell |
4,144
-337,861
| -99% | -$4.16M | ﹤0.01% | 3817 |
|
|
2013
Q2 | $3.22M | Buy |
+342,005
| New | +$3.22M | ﹤0.01% | 2234 |
|